HIV and HCV Screening, and Pre-Exposure Prophylaxis Among Managed Care Beneficiaries with Substance Use Disorders: A Cross-Sectional Study from a Single State

Abstract Purpose: Screening for HIV and Hepatitis C (HCV) is critical in caring for individuals with substance use disorders (SUD). This is particularly relevant in identifying prescribing habits for Pre-Exposure Prophylaxis (PrEP). The objectives were to examine HIV and HCV screening rates, and PrEP prescription among managed care beneficiaries with SUD and without an HIV diagnosis and determine the factors associated with the screenings and PrEP prescriptions. Methods: We conducted a retrospective cross-sectional analysis (January–December 2021) of managed care claims